orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
Company profile
Ticker
OFIX
Exchange
Website
CEO
Jon C. Serbousek
Employees
Location
Fiscal year end
Industry (SIC)
Former names
ORTHOFIX INTERNATIONAL N V
SEC CIK
Corporate docs
Subsidiaries
Orthofix Australia • Orthofix do Brasil Ltda. • Orthofix S.A. • Orthofix GmbH • Orthofix Spine GmbH • Orthofix S.r.l. • Orthofix Netherlands B.V. • Implantes y Sistemas Medicos, Inc. • Orthofix AG • Orthofix Limited ...
OFIX stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
19 Apr 24
S-8
Registration of securities for employees
15 Apr 24
8-K
Departure of Directors or Certain Officers
12 Apr 24
S-8
Registration of securities for employees
15 Mar 24
10-K
2023 FY
Annual report
5 Mar 24
8-K
Orthofix Reports Fourth Quarter and Full Year 2023 Results
5 Mar 24
8-K
Julie Andrews Begins as New Chief Financial Officer at Orthofix
17 Jan 24
S-8
Registration of securities for employees
12 Jan 24
8-K
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
9 Jan 24
S-8
Registration of securities for employees
8 Jan 24
Transcripts
OFIX
Earnings call transcript
2023 Q4
5 Mar 24
OFIX
Earnings call transcript
2023 Q3
8 Nov 23
OFIX
Earnings call transcript
2023 Q2
8 Aug 23
OFIX
Earnings call transcript
2023 Q1
9 May 23
OFIX
Earnings call transcript
2022 Q4
6 Mar 23
OFIX
Earnings call transcript
2022 Q3
3 Nov 22
OFIX
Earnings call transcript
2022 Q2
7 Aug 22
OFIX
Earnings call transcript
2022 Q1
6 May 22
OFIX
Earnings call transcript
2021 Q4
25 Feb 22
OFIX
Earnings call transcript
2021 Q3
5 Nov 21
Latest ownership filings
SC 13D/A
ENGINE CAPITAL, L.P.
22 Apr 24
4
Jorge Andres Cedron
17 Apr 24
3
Jorge Andres Cedron
17 Apr 24
4
Kimberley A. Elting
12 Apr 24
4
CATHERINE M BURZIK
9 Apr 24
4
Kimberley A. Elting
3 Apr 24
4
Geoffrey C Gillespie
3 Apr 24
4
Geoffrey C Gillespie
19 Mar 24
3
Geoffrey C Gillespie
19 Mar 24
4
Alan Lee Bazaar
12 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 33.66 mm | 33.66 mm | 33.66 mm | 33.66 mm | 33.66 mm | 33.66 mm |
Cash burn (monthly) | 1.31 mm | 1.50 mm | 9.46 mm | 11.47 mm | (no burn) | 3.06 mm |
Cash used (since last report) | 8.94 mm | 10.20 mm | 64.33 mm | 78.01 mm | n/a | 20.80 mm |
Cash remaining | 24.72 mm | 23.47 mm | -30.67 mm | -44.34 mm | n/a | 12.86 mm |
Runway (months of cash) | 18.8 | 15.6 | -3.2 | -3.9 | n/a | 4.2 |
Institutional ownership, Q3 2023
91.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 157 |
Opened positions | 27 |
Closed positions | 17 |
Increased positions | 49 |
Reduced positions | 65 |
13F shares | Current |
---|---|
Total value | 436.51 bn |
Total shares | 34.13 mm |
Total puts | 15.50 k |
Total calls | 0.00 |
Total put/call ratio | Infinity |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 5.96 mm | $76.69 bn |
Rubric Capital Management | 3.43 mm | $44.17 bn |
Armistice Capital | 2.96 mm | $38.12 bn |
Vanguard | 2.49 mm | $31.97 bn |
First Light Asset Management | 1.85 mm | $23.82 bn |
STT State Street | 1.50 mm | $19.27 bn |
Segall Bryant & Hamill | 1.34 mm | $17.27 bn |
Dimensional Fund Advisors | 897.37 k | $11.54 bn |
Geode Capital Management | 748.35 k | $9.62 bn |
Sio Capital Management | 650.00 k | $8.36 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Jorge Andres Cedron | Common Stock | Grant | Acquire A | No | No | 13.09 | 28,648 | 375.00 k | 28,648 |
15 Apr 24 | Jorge Andres Cedron | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 13.09 | 64,817 | 848.45 k | 64,817 |
11 Apr 24 | Elting Kimberley A. | Common Stock | Payment of exercise | Dispose F | No | No | 13.95 | 2,938 | 40.99 k | 232,014 |
8 Apr 24 | Burzik Catherine M | Common Stock | Payment of exercise | Dispose F | No | No | 14.23 | 47,486 | 675.73 k | 112,803 |
1 Apr 24 | Geoffrey C Gillespie | Common Stock | Payment of exercise | Dispose F | No | No | 14.06 | 70 | 984.20 | 40,772 |
News
Roth MKM Maintains Neutral on Orthofix Medical, Raises Price Target to $15
7 Mar 24
Orthofix Medical Earlier Reported Q4 EPS $(0.59) Misses $(0.08) Estimate, Sales $200.41M Beat $195.31M Estimate
5 Mar 24
Orthofix Expects 2024 Net Sales To Range $785M-$795M (Est. $741.55M), Expects To Exit Q4 2024 Free Cash Flow Positive
5 Mar 24
Earnings Scheduled For March 5, 2024
5 Mar 24